New Horizons in Food Allergy: Best Practices & Treatment Advances for Unmet Needs: A Clinical Transfers®
Program Overview
The management of food allergies is rapidly advancing with novel therapies offering hope to millions affected by this disease. Developed in partnership with FARE (Food Allergy Research & Education), this educational program explores the disease- and treatment-related burdens faced by individuals with food allergies, highlighting important unmet needs in underserved communities. You will gain insights into the pathophysiology of food allergies and learn how to apply recent treatment advancements, such as anti-IgE antibody therapy and oral immunotherapy, in clinical practice.
Primary care physicians, allergists and immunologists, pediatricians, nurses, and other clinicians who treat patients with food allergies.
Educational Objectives
Upon completion of this activity, participants should be better able to:
Identify the disease- and treatment-related burdens of the underserved patient populations with food allergies
Describe the pathophysiology and resulting signs and symptoms of IgE-mediated food allergy
Assess the benefits and limitations of current strategies for managing food allergies
Integrate recent data on biologic therapy for food allergies into clinical practice
Activity Faculty
Anita Roach, MS
Vice President, Health Equity and Community Engagement
FARE (Food Allergy Research & Education)
McLean, VA
R. Sharon Chinthrajah, MD
Associate Professor, Medicine Associate Professor, Pediatrics
Sean N. Parker Center for Allergy and Asthma Research
Stanford University
Stanford, CA
Edwin H. Kim, MD, MS
Associate Professor, University of North Carolina School of Medicine Chief, Division of Pediatric Allergy and Immunology Director, UNC Food Allergy Initiative
Chapel Hill, NC